Addex Therapeutics Ltd (ADXN) Financials

ADXN Assets vs Liabilities

DateAssetsLiabilities
Dec. 31, 2025 ? ?
Sept. 30, 2025 9.2 million 1.7 million
June 30, 2025 10.7 million 1.6 million
March 31, 2025 10.8 million 1.3 million

ADXN Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 ? ?
Sept. 30, 2025 -669511 ?
June 30, 2025 -529528 ?
March 31, 2025 -679267 35466

ADXN Net Income

No data available :(

ADXN Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 - - -
Sept. 30, 2025 2.8 million 36368 45892
June 30, 2025 2.9 million 38967 48415
March 31, 2025 3.2 million 37218 45611

ADXN Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2025 ?
Sept. 30, 2025 1.2 million
June 30, 2025 967575
March 31, 2025 929821

ADXN Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 - 66488 928692 -
Sept. 30, 2025 - 107050 577493 -
June 30, 2025 - 86385 519582 -
March 31, 2025 - 36967 508366 -

ADXN Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 179209 -
Sept. 30, 2025 37322 -
June 30, 2025 45878 295706
March 31, 2025 1710 177066

ADXN

Price: $6.33

52 week price:
5.41
12.05

Earnings Per Share: -9.22 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: Switzerland

Volume: 497200

Market Capitalization: 4.2 million

Links: